Analysis of HLA-DRB1^*O901-binding HPV-16 E7 Helper T cell Epitope.
HLA-DRB1^*O901 结合 HPV-16 E7 辅助 T 细胞表位分析。
基本信息
- 批准号:13670472
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Objective : This study sought to determine the human papillomavirus(HPV)-16E7 epitopes that would be presented by HLA-DR molecules to CD4-positive T cells in patients with cervical carcinoma.Methods : HLA-DR binding assays were performed using HPV-16 E7-derived synthetic peptides and, after incubation with these DR-binding peptides, helper T cell frequencies were analyzed in patients whose HLA and HPV genotypes were confirmed.Results and Conclusion : We determined that the E7d peptide,^<61>CDSTLRLCVQSTHVDIRTL^<80>E, was bound by HLA-DRB1^*0901. An increased frequency(0.3-2.4%) of type 2 helper T cell responses was found in HLA-DRB1^*0901-positive patients with cervical dyaplasia and carcinoma. We found that when IL-12 was combined with E7d-peptide stimulation in vitro, the frequency of type 1helper T cell responses also increased in the patients with carcinoma. Thus HPV-16 E7d peptide as an HLA-DRB1^*0901-restricted helper T cell epitope might usefully be incorporated in understanding immunological mechanism and immunotherapy for this disease.
目的:本研究旨在确定人乳头瘤病毒(HPV)-16E7表位,这些表位将由HLA-DR分子呈递给宫颈癌患者的CD 4阳性T细胞。使用HPV-16 E7衍生的合成肽进行HLA-DR结合测定,并且在与这些DR结合肽孵育后,结果和结论:我们确定了E7 d肽^<61>CDSTLRLCVQSTHVDIRTL^<80>E与HLA-DRB 1 ^*0901结合。在HLA-DRB 1 ^*0901阳性的宫颈不典型增生和宫颈癌患者中,发现2型辅助性T细胞反应的频率增加(0.3-2.4%)。我们发现,当IL-12与E7 d-肽在体外联合刺激时,肿瘤患者的1型辅助性T细胞应答频率也增加。因此,HPV-16 E7 d肽作为HLA-DRB 1 ^*0901限制性辅助性T细胞表位可能有助于了解这种疾病的免疫机制和免疫治疗。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mitsuo Okubo, Maki Saito, Hiroki Inoku, Ranko Hirata, Masami Yanagisawa, Satoru Takeda, Katsuyuki Kinoshita, Hiroo.: "Analysis of HLA-DRB1^*0901-binding HPV-16 E7 Helper T cell Epitope."Journal of Obstetrics and Gynaecology Research. 30(in press). 120-129
Mitsuo Okubo、Maki Saito、Hiroki Inoku、Ranko Hirata、Masami Yanagisawa、Satoru Takeda、Katsuyuki Kinoshita、Hiroo.:“HLA-DRB1^*0901 结合 HPV-16 E7 辅助 T 细胞表位的分析。”妇产科杂志
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mitsuo Okubo, Maki Saito, Hiroki Inoku, Ranko Hirata, Masami Yanagisawa, Satoru Takeda, Katsuyuki Kinoshita, Hiroo Maeda.: "Analysis of HLA-DRB1^*0901-binding HPV-16 E7 Helper T cell Epitope."Journal of Obstetrics and Gynaecology Research. 30. 120-129 (20
Mitsuo Okubo、Maki Saito、Hiroki Inoku、Ranko Hirata、Masami Yanagisawa、Satoru Takeda、Katsuyuki Kinoshita、Hiroo Maeda.:“HLA-DRB1^*0901 结合 HPV-16 E7 辅助 T 细胞表位的分析。”妇产科杂志
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mitsuo Okubo, Maki Saito, Hiroki Inoku, Ranko Hirata, Masami Yanagisawa, Satoru Takeda, Katsuyuki Kinoshita, Hiroo Maeda: "Analysis of HLA-DRB1^*0901-binding HPV-16 E7 Helper T cell Epitope."Journal of Obstetrics and Gynaecology Research. 30. 120-129 (200
Mitsuo Okubo、Maki Saito、Hiroki Inoku、Ranko Hirata、Masami Yanagisawa、Satoru Takeda、Katsuyuki Kinoshita、Hiroo Maeda:“分析 HLA-DRB1^*0901 结合 HPV-16 E7 辅助 T 细胞表位。”妇产科杂志
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OKUBO Mitsuo其他文献
OKUBO Mitsuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Large Scale T Cell Epitope Discovery: Global identification of epitopes derived from Zika (ZIKV) and Chikungunya (CHIKV) viruses following natural infection and vaccination
大规模 T 细胞表位发现:在自然感染和疫苗接种后对寨卡病毒 (ZIKV) 和基孔肯雅病毒 (CHIKV) 衍生的表位进行全面鉴定
- 批准号:
10020640 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别:
Large Scale T Cell Epitope Discovery: Genome-wide characterization of T cell epitopes from Bordetella pertussis in vaccination and natural infection
大规模 T 细胞表位发现:疫苗接种和自然感染中百日咳博德特氏菌 T 细胞表位的全基因组特征
- 批准号:
10616655 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别:
Large Scale T Cell Epitope Discovery: Proteome-wide characterization of T cell epitopes from Mycobacterium tuberculosis in vaccination and active infection
大规模 T 细胞表位发现:疫苗接种和主动感染中结核分枝杆菌 T 细胞表位的全蛋白质组表征
- 批准号:
10610271 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别:
Large Scale T Cell Epitope Discovery: Genome-wide characterization of T cell epitopes from Bordetella pertussis in vaccination and natural infection
大规模 T 细胞表位发现:疫苗接种和自然感染中百日咳博德特氏菌 T 细胞表位的全基因组特征
- 批准号:
10439413 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别:
Large Scale T Cell Epitope Discovery: Local and Systemic T cell Response to Herpes Simplex Virus
大规模 T 细胞表位发现:局部和全身 T 细胞对单纯疱疹病毒的反应
- 批准号:
10894580 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别:
Large Scale T Cell Epitope Discovery:Global identification of epitopes derived from Zika (ZIKV), Chikungunya (CHIKV) viruses following natural infection and vaccination
大规模 T 细胞表位发现:在自然感染和疫苗接种后对寨卡病毒 (ZIKV)、基孔肯雅病毒 (CHIKV) 衍生的表位进行全球鉴定
- 批准号:
10889875 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别:
Large Scale T Cell Epitope Discovery: Proteome-wide characterization of T cell epitopes from Mycobacterium tuberculosis in vaccination and active infection
大规模 T 细胞表位发现:疫苗接种和主动感染中结核分枝杆菌 T 细胞表位的全蛋白质组表征
- 批准号:
10892741 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别: